Drug Profile
Influenza virus vaccine intranasal - ID Biomedical
Alternative Names: FluINsure; Influenza virus vaccine intranasal - IntellivaxLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator ID Biomedical Corporation; Intellivax
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 28 Feb 2007 Discontinued - Phase-I for Influenza virus infections in USA (Intranasal)
- 28 Feb 2007 Discontinued - Phase-II for Influenza virus infections in Canada (Intranasal)
- 28 Feb 2007 Discontinued - Phase-II for Influenza virus infections in United Kingdom (Intranasal)